REGENXBIO's Nina Hunter, Ph.D. Details the Accelerated Approval Pathway for Gene Therapies

Cell & Gene: The Podcast

English - February 17, 2022 09:00 - 17 minutes - 12.3 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors

Next Episode: Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma

We love to hear from our listeners. Send us a message.

REGENXBIO's VP of Regulatory and Science Policy, Nina Hunter, Ph.D., shares potential solutions to gene therapies' regulatory roadblocks and why the accelerated approval pathway is so pertinent.